Professor Stefania Basili
Sapienza University of Rome, Rome (Italy)
Follow
Contributor content
Journal
Lesson learned from the COMPASS and VOYAGER PAD trials: dual pathway inhibition as a new antithrombotic paradigm?
6 September 2021
